Alan Boyd: Happiest flying kitesBMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j689 (Published 22 February 2017) Cite this as: BMJ 2017;356:j689
Alan Boyd, 62, is president of the faculty of pharmaceutical medicine and an honorary professor at Birmingham Medical School, from which he graduated in biochemistry and medicine.
He worked in drug development for Glaxo, ICI (later Zeneca), and Ark Therapeutics, where he led the development of gene based drugs.
In 2005 he launched Boyd Consultants, a company based in Crewe, which focuses on supporting universities and early stage life science businesses.
His ambition for the faculty is to make it the “go-to expert” on matters relating to pharmaceutical medicine.
What was your earliest ambition?
I always wanted to be a doctor. I grew up on a council estate in Blackpool, and only a few people made it to grammar school from there, let alone university. People would therefore tell my parents that I would grow out of it, but I never did.
Who has been your biggest inspiration?
Owen Wade and Martin Kendall at Birmingham University …